Dr. David W. Green MBiol. CBiol.
BSc. Joint Hons. (Reading, UK), PhD. (Aston,UK)
Research Officer at QEI
Adjunct Research Fellow at the Australian Institute of Bioengineering and Nanotechnology, University of Queensland.
Visiting Research Fellow in Medical Sciences at the: Institute of Health and Biomedical Innovation, Queensland University of Technology.
Dr. David Green joined QEI in July 2009, to work with Professor Traian Chirila, on regenerative medicine for the eye.
David started his professional research career at the University of Southampton in the UK in 2000. His research covered a wide spectrum of disciplines to engineer new bone, cartilage and soft tissue for orthopaedic surgery and breast reconstruction surgery.
The focus of his work was to develop biologically inspired “living” biomaterials using human stem cells.
Prior to arriving in Brisbane Dr. Green was appointed at the McDiarmid Institute for Advanced Materials
and Nanotechnology, New Zealand on a commercialization project to develop biomimetic materials for bone and skin repair and regeneration.
Dr. Green has strived to develop a range of bio-inspired (learning lessons from nature) biomaterial led solutions for stem cell therapies. These have been applied to gene delivery, pharmaceutical drug, nutrient and growth factor delivery for human tissue repair and rejuventation. The materials and structures are made using self-assembling and self-organizing "green" chemistry.
My research programme is to develop an ocular tissue glue, sugar-coated silks for corneal restoration, polysaccharide nanocapsules for ocular drug delivery, a biomimetic synthetic cornea, nanostructured membranes for cornea and retina, and customized biomaterial niches for ocular stem cell selection, protection, tissue transplantation and tissue regeneration.
Dr. Green works in close association with Professor Damien Harkin (QEI and QUT), Dr Tony Kwan, Professor Lawrence Hirst and Dr Peter Madden (QEI). He also has collaborations with researchers at the Australian Institute of Marine Sciences, James Cook University and at the Australian Institute of Bioengineering and Nanotechnology (AIBN), University of Queensland. The primary aim is to translate his applied research directly to the clinic.
|
